KINDLER JEFFREY B 4
4 · PRECIGEN, INC. · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
Precigen (PGEN) Director Jeffrey Kindler Receives Award
What Happened Jeffrey B. Kindler, a director of Precigen, was granted stock as compensation on March 10, 2026. He was issued 19,658 common shares (valued at $3.51 each, total $69,000) in lieu of his annual retainer, plus two restricted stock unit (RSU) awards totaling 76,685 RSUs (35,612 and 41,073 RSUs). The 19,658 shares are delivered now; the RSUs are derivative awards that represent contingent rights to receive common stock in the future.
Key Details
- Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (timely within the two‑business‑day window).
- Grants: 19,658 common shares acquired at $3.51/share (cash value $69,000); 35,612 RSUs and 41,073 RSUs granted at $0 (derivative awards).
- RSU terms: Each RSU equals one contingent share; all RSUs vest in full on March 10, 2027 (Footnotes F2, F3).
- Reason: 19,658 shares issued in lieu of the director’s $69,000 annual retainer (Footnote F1).
- Shares owned after transaction: Not specified in the filing.
Context
- These entries are awards/compensation (transaction code A), not open‑market purchases or sales. Awards are common for director compensation and do not by themselves indicate buying or selling sentiment.
- RSUs are derivative grants that convert to actual shares only upon vesting (here, on 3/10/2027); no immediate sale or option exercise was reported.
Insider Transaction Report
Form 4
PRECIGEN, INC.PGEN
KINDLER JEFFREY B
Director
Transactions
- Award
Common Stock
[F1]2026-03-10$3.51/sh+19,658$69,000→ 130,261 total - Award
Restricted Stock Units
[F2][F3]2026-03-10+35,612→ 35,612 total→ Common Stock (35,612 underlying) - Award
Option to Purchase Common Stock (Right to Buy)
2026-03-10+41,073→ 41,073 totalExercise: $3.51From: 2026-03-10Exp: 2036-03-10→ Common Stock (41,073 underlying)
Footnotes (3)
- [F1]The shares were issued to the reporting person in lieu of an annual retainer of $69,000.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
- [F3]The RSUs vest in full on March 10, 2027.
Signature
/s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact|2026-03-12